Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berodual Respimat vs MDI in COPD with Poor Technique
NCT02176187Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2003
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fenoterol + ipratropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Percentage of dose in the whole lung. Started Apr 2003; status: terminated.
02
Drugs
fenoterol + ipratropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02176187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176187.